NCT06975956

Brief Summary

Pelvic organ prolapse is a condition that affects sexual health and quality of life at all ages. The efficacy of the Manchester operation planned in appropriate patients and its effects on the sexual function and quality of life of the patient were investigated and it was thought that uterine preservation should be offered as a treatment option in the young age group of patients who want uterine preservation and in cases with comorbidity and short operation time required.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2023

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

April 28, 2025

Completed
18 days until next milestone

First Posted

Study publicly available on registry

May 16, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2025

Completed
Last Updated

November 25, 2025

Status Verified

August 1, 2025

Enrollment Period

2.7 years

First QC Date

April 28, 2025

Last Update Submit

November 22, 2025

Conditions

Keywords

Pelvic organ prolapseManchester operation

Outcome Measures

Primary Outcomes (3)

  • Change in Sexual Function as will be measured by the Female Sexual Function Index (FSFI) in patients undergoing Manchester operation for pelvic organ prolapse.

    The FSFI is a 19-item questionnaire evaluating six domains(desire, arousal, lubrication, orgasm, sexual satisfaction and pain) of female sexual function. Total scores range from 2 to 36; higher scores reflect better sexual function

    Preoperative and 6 months postoperative

  • Change in Quality of Life as will be measured by Prolapse quality of life tests (PQOL) in patients undergoing Manchester operation for pelvic organ prolapse

    PQOL questionnaire consists of 20 questions about general health perceptions, prolapse impact, role imitation, physical limitations, social limitation, personal relationships, emotions, sleep/energy, severity measures. Each section is scored with a minimum score of 0 and a maximum score of 100. A high total score indicates a greater impairment of quality of life.

    Preoperative and 6 months postoperative

  • Change in Pelvic Organ Support as will be measured by the Pelvic Organ

    The POP-Q system measures vaginal point locations relative to the hymen in centimeters (e.g., Aa, Ba, C, D points). Improvement is reflected by a reduction in positive or elevated values.

    Preoperative and 6 months postoperative

Study Arms (1)

Female patients who underwent Manchester operation for pelvic organ prolapse.

Complaints, demographic characteristics and gynecologic examinations of the patients who underwent Manchester operation will be performed. Preoperative and postoperative 6th month pelvic examination will include POP Q scoring, Female Sexual Function Index (FSFI) questionnaire consisting of 19 questions to evaluate sexual life, Prolapse Quality of Questionnaire (PQOL) consisting of 20 questions to evaluate quality of life.

Eligibility Criteria

Age18 Years - 99 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsPatients undergoing Manchester operation for pelvic organ prolapse
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients undergoing Manchester operation for pelvic organ prolapse

You may qualify if:

  • Patients undergoing Manchester operation for pelvic organ prolapse

You may not qualify if:

  • Patients who refused to participate in the study. Patients undergoing hysterectomy for pelvic organ prolapse, cancer patients, patients with uterine, cervical and ovarian malignancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bağcılar Training and Reserach Hospital

Istanbul, Turkey (Türkiye)

Location

Related Publications (1)

  • Park YJ, Kong MK, Lee J, Kim EH, Bai SW. Manchester Operation: An Effective Treatment for Uterine Prolapse Caused by True Cervical Elongation. Yonsei Med J. 2019 Nov;60(11):1074-1080. doi: 10.3349/ymj.2019.60.11.1074.

MeSH Terms

Conditions

Pelvic Organ Prolapse

Condition Hierarchy (Ancestors)

ProlapsePathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Target Duration
6 Months
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator, Specialist Physician in Obstetrics and Gynecology

Study Record Dates

First Submitted

April 28, 2025

First Posted

May 16, 2025

Study Start

January 1, 2023

Primary Completion

August 30, 2025

Study Completion

September 30, 2025

Last Updated

November 25, 2025

Record last verified: 2025-08

Locations